Search results
Jan 17, 2022 · What Is the Guaifenesin Protocol? The Guaifenesin Protocol was developed by Paul St. Amand, MD, an endocrinologist who has FMS, as do several members of his family. At its root is the theory that our cells aren't able to make enough energy because of low levels of adenosine triphosphate (ATP) , and that energy deprivation leads to the many ...
- Adrienne Dellwo
IMPORTANT ANNOUNCEMENT: Dr. St. Amand, M.D. is Retiring in March 2020. Dr. St. Amand’s office will be closing as scheduled on March 27, 2020 at 5:00 p.m. UNTIL THEN WE ARE OPEN. You can reach us by telephone at (310) 577-7510 until 3/27/2020. Dr. St. Amand is continuing to see patients.
The guaifenesin protocol is a fibromyalgia treatment pioneered by fibromyalgia specialist Dr. Paul St. Amand. There is no medication (yet) that has been shown to make the syndrome disappear, but Dr. St. Amand, an 92-year-old fibromyalgia specialist (who himself has the syndrome and who has been working with fibromyalgia patients for over 50 ...
Paul St. Amand, M.D., Assistant Clinical Professor of Medicine, Harbor UCLA, along with many other physicians around the world have successfully treated thousands of patients using guaifenesin, an old generic and inexpensive drug.
R. Paul St. Amand M.D. is a highly qualified Endocrinologist who has devoted over 50 years of his practice to researching and treating Fibromyalgia. A graduate of Tufts University School of Medicine, he has been on the teaching staff at the Los Angeles County Harbor-UCLA Medical Center Department of Endocrinology for over 40 years.
R. Paul St. Amand, M.D. Associate Clinical Professor of Medicine Endocrinology--Harbor-UCLA Claudia Craig Marek Medical Assistant [email protected] Important: Do not assume fibromyalgia is the cause of all symptoms. When in doubt or confronted with new problems, please consult your personal physician or appropriate specialist.
Guaifenesin protocol is an unapproved treatment for fibromyalgia suggested in the 1990s by R. Paul St. Amand. The protocol involves three parts: titrating the guaifenesin dosage, avoiding salicylates, and following a low-carbohydrate diet if the patient is hypoglycemic.
